Web Event: Understanding and Addressing Racial Disparities in Cancer Outcomes, Care, and Treatment

Thursday, Feb 3, 2022 at 9:00 AM PT/12:00 PM ET

The COVID-19 pandemic has raised awareness and sharpened the discussion of systemic racial disparities in the U.S. health care system. These inequities existed long before the pandemic and have been recognized for decades, yet they continue and, in some cases, have worsened.

Cancer consistently ranks as one of the leading causes of death in the country, providing a focal point for a deeper conversation about the many factors contributing to the racial inequities we see in cancer outcomes, care, and treatment.

The American Society of Clinical Oncology (ASCO) and KFF are hosting a web event featuring oncologists, patient advocates, and policy researchers with expertise in equity and cancer care to examine persistent racial disparities in cancer. Expert panelists will share real-life experiences, provide context on the latest data, and discuss a range of actions which could help ensure that all individuals with cancer receive the highest quality, equitable cancer care and help to eliminate disparities in cancer outcome.

The event, open to the public, will feature the release of a new KFF brief presenting the latest data on racial cancer disparities and discussing the multiple factors that drive them.

RSVP for the web event.

Moderator

• Samantha Artiga, Vice President and Director of the Racial Equity and Health Policy Program at KFF

Overview of Latest Data on Cancer Disparities

• Latoya Hill, Senior Analyst, Racial Equity and Health Policy, KFF

Perspectives

• Carol Brown, MD, FACOG, FACS, Senior Vice President and Chief Health Equity Officer, Nicholls-Biondi Chair for Health Equity, Memorial Sloan Kettering Cancer Center
• Wenora Johnson, Research/Patient Advocate representing Fight Colorectal Cancer and Patient-Centered Outcomes Research Institute
• Lori Pierce, MD, FASCO, FASTRO, Professor and Vice Provost for Academic and Faculty Affairs, University of Michigan; Director, Michigan Radiation Oncology Quality Consortium; Board Chair of the American Society of Clinical Oncology

Audience Q&A with panelists and co-author of forthcoming brief, Michelle Tong, MD Candidate, UCSF-KFF Health Policy Fellow.

Founded in 1964, the American Society of Clinical Oncology, Inc. (ASCO®) is committed to making a world of difference in cancer care. As the world's leading organization of its kind, ASCO represents nearly 45,000 oncology professionals who care for people living with cancer. Through research, education, and promotion of the highest-quality patient care, ASCO works to conquer cancer and create a world where cancer is prevented or cured, and every survivor is healthy. ASCO is supported by its affiliate organization, the Conquer Cancer Foundation. Learn more at www.ASCO.org, explore patient education resources at www.Cancer.Net, and follow us on Facebook, Twitter, LinkedIn, and YouTube.